A role for tyrosinase-related protein 1 in 4-tert-butylphenol-induced toxicity in melanocytes: Implications for vitiligo

American Journal of Pathology

Volumn 169, Issue 5, 2006, Pages 1652-1662

  Manga, Prashiela ^a   Sheyn, David ^a   Yang, Fan ^a   Sarangarajan, Rangaprasad ^a   Boissy, Raymond E ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 TERT BUTYLPHENOL; ACTIN; HYDROGEN PEROXIDE; MICROPHTHALMIA ASSOCIATED TRANSCRIPTION FACTOR; TYROSINASE RELATED PROTEIN 1; ALPHA INTERMEDIN; BUTYLPHEN; MELANIN; MESSENGER RNA; OXIDOREDUCTASE; PHENOL DERIVATIVE; TYROSINASE RELATED PROTEIN; TYROSINASE-RELATED PROTEIN;

ARTICLE; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DEPIGMENTATION; HUMAN; HUMAN CELL; MELANOCYTE; MELANOMA; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUNCH BIOPSY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; VITILIGO; WESTERN BLOTTING; CELL CULTURE; DOWN REGULATION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY;

ALPHA-MSH; CELL DEATH; CELLS, CULTURED; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; MELANINS; MELANOCYTES; MELANOMA; MICROPHTHALMIA-ASSOCIATED TRANSCRIPTION FACTOR; OXIDATIVE STRESS; OXIDOREDUCTASES; PHENOLS; RNA, MESSENGER; VITILIGO;

EID: 38049010534     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050769     Document Type: Article

References (51)

1. Arrunategui A, Arroyo C, Garcia L, Covelli C, Escobar C, Carrascal E, Falabella R: Melanocyte reservoir in vitiligo. Int J Dermatol 1994, 33:484-487
2. Lerner AB: On the etiology of vitiligo and gray hair. Am J Med 1971, 51:141-147
3. Nordlund JJ: The pigmentary system and inflammation. Pigment Cell Res 1992, 5:362-365
4. Le Poole C, Boissy RE: Vitiligo. Semin Cutan Med Surg 1997, 16:3-14
5. Nath SK, Majumder PP, Nordlund JJ: Genetic epidemiology of vitiligo: multilocus recessivity cross-validated. Am J Hum Genet 1994, 55:981-990
6. Boissy RE, Manga P: On the etiology of contact/occupational vitiligo. Pigment Cell Res 2004, 17:208-214
7. Cummings MP, Nordlund JJ: Chemical leukoderma: fact or fancy. Am J Contact Dermatitis 1995, 6:122-127
8. Gellin GA, Maibach H: Chemically induced depigmentation. Models in Dermatology. Edited by H Maibach, N Lowe. Basel, Karger, 1985, pp 443-459
9. James O, Mayes RW, Stevenson CJ: Occupational vitiligo induced by p-tert-butylphenol: a systemic disease? Lancet 1977, 2:1217-1219
10. Gellin GA, Possick PA, Perone VB: Depigmentation from 4-tertiary butyl catechol - an experimental study. J Invest Dermatol 1970, 55:190-197
11. Rodriguez-Lopez JN, Fenoll LG, Penalver MJ, Garcia-Ruiz PA, Varon R, Martinez-Ortiz F, Garcia-Canovas F, Tudela J: Tyrosinase action on monophenols: evidence for direct enzymatic release of o-diphenol. Biochim Biophys Acta 2001, 1548:238-256
12. Thorneby-Andersson K, Sterner O, Hansson C: Tyrosinase-mediated formation of a reactive quinone from the depigmenting agents, 4-tertbutylphenol and 4-tert-butylcatechol. Pigment Cell Res 2000, 13:33-38
13. Yang F, Boissy RE: Effects of 4-tertiary butylphenol on the tyrosinase activity in human melanocytes. Pigment Cell Res 1999, 12:237-245
14. Yang F, Sarangarajan R, Le Poole IC, Medrano EE, Boissy RE: The cytotoxicity and apoptosis induced by 4-tertiary butylphenol in human melanocytes are independent of tyrosinase activity. J Invest Dermatol 2000, 114:157-164
15. Yang F, Abdel-Malek Z, Boissy RE: Effects of commonly used mitogens on the cytotoxicity of 4-tertiary butylphenol to human melanocytes. In Vitro Cell Dev Biol Anim 1999, 35:566-570
16. Suzuki I, Cone RD, Im S, Nordlund J, Abdel-Malek ZA: Binding of melanotropic hormones to the melanocortin receptor MC1R on human melanocytes stimulates proliferation and melanogenesis. Endocrinology 1996, 137:1627-1633
17. Widlund HR, Fisher DE: Microphthalamia-associated transcription factor: a critical regulator of pigment cell development and survival. Oncogene 2003, 22:3035-3041
18. Fang D, Setaluri V: Role of microphthalmia transcription factor in regulation of melanocyte differentiation marker TRP-1. Biochem Biophys Res Commun 1999, 256:657-663
19. Xu W, Gong L, Haddad MM, Bischof O, Campisi J, Yeh ET, Medrano EE: Regulation of microphthalmia-associated transcription factor MITF protein levels by association with the ubiquitin-conjugating enzyme hUBC9. Exp Cell Res 2000, 255:135-143
20. Larribere L, Hilmi C, Khaled M, Gaggioli C, Bille K, Auberger P, Ortonne JP, Ballotti R, Bertolotto C: The cleavage of microphthalmia-associated transcription factor, MITF, by caspases plays an essential role in melanocyte and melanoma cell apoptosis. Genes Dev 2005, 19:1980-1985
21. Jimenez-Cervantes C, Martinez-Esparza M, Perez C, Daum N, Solano F, Garcia-Borron JC: Inhibition of melanogenesis in response to oxidative stress: transient downregulation of melanocyte differentiation markers and possible involvement of microphthalmia transcription factor. J Cell Sci 2001, 114:2335-2344
22. Jimbow K, Chen H, Park JS, Thomas PD: Increased sensitivity of melanocytes to oxidative stress and abnormal expression of tyrosinase-related protein in vitiligo. Br J Dermatol 2001, 144:55-65
23. Schallreuter KU, Moore J, Wood JM, Beazley WD, Peters EM, Marles LK, Behrens-Williams SC, Dummer R, Blau N, Thony B: Epidermal H(2)O(2) accumulation alters tetrahydrobiopterin (6BH4) recycling in vitiligo: identification of a general mechanism in regulation of all 6BH4-dependent processes? J Invest Dermatol 2001, 116:167-174
24. Yildirim M, Baysal V, Inaloz HS, Kesici D, Delibas N: The role of oxidants and antioxidants in generalized vitiligo. J Dermatol 2003, 30:104-108
25. Abdel-Malek Z, Swope VB, Pallas J, Krug K, Nordlund JJ: Mitogenic, melanogenic, and cAMP responses of cultured neonatal human melanocytes to commonly used mitogens. J Cell Physiol 1992, 150:416-425
26. Le Poole IC, Boissy RE, Sarangarajan R, Chen J, Forristal JJ, Sheth P, Westerhof W, Babcock G, Das PK, Saelinger CB: PIG3V, an immortalized human vitiligo melanocyte cell line, expresses dilated endoplasmic reticulum. In Vitro Cell Dev Biol Anim 2000, 36:309-319
27. Kadekaro AL, Kanto H, Kavanagh R, Abdel-Malek ZA: Significance of the melanocortin 1 receptor in regulating human melanocyte pigmentation, proliferation, and survival. Ann NY Acad Sci 2003, 994:359-365
28. Guerra L, Mordoh J, Slavutsky I, Larripa I, Medrano EE: Characterization of IIB-MEL-J: a new and highly heterogenous human melanoma cell line. Pigment Cell Res 1989, 2:504-509
29. Zhao H, Eling DJ, Medrano EE, Boissy RE: Retroviral infection with human tyrosinase-related protein-1 (TRP-1) cDNA upregulates tyrosinase activity and melanin synthesis in a TRP-1-deficient melanoma cell line. J Invest Dermatol 1996, 106:744-752
30. Zdarsky E, Favor J, Jackson IJ: The molecular basis of brown, an old mouse mutation, and of an induced revertant to wild type. Genetics 1990, 126:443-449
31. Kadekaro AL, Kavanagh R, Kanto H, Terzieva S, Hauser J, Kobayashi N, Schwemberger S, Cornelius J, Babcock G, Shertzer HG, Scott G, Abdel-Malek ZA: alpha-Melanocortin and endothelin-1 activate antiapoptotic pathways and reduce DNA damage in human melanocytes. Cancer Res 2005, 65:4292-4299
32. Kadekaro AL, Kavanagh RJ, Wakamatsu K, Ito S, Pipitone MA, Abdel-Malek ZA: Cutaneous photobiology. The melanocyte vs. the sun: who will win the final round? Pigment Cell Res 2003, 16:434-447
33. Boissy RE, Zhao H, Oetting WS, Austin LM, Wildenberg SC, Boissy YL, Zhao Y, Sturm RA, Hearing VJ, King RA, Nordlund JJ: Mutation in and the lack of expression of tyrosinase-related protein-1 (TRP-1) in melanocytes from an individual with brown oculocutaneous albinism: a new subtype of albinism classified as "OCA3". Am J Hum Genet 1996, 58:1145-1156
34. Manga P, Kromberg JG, Box NF, Sturm RA, Jenkins T, Ramsay M:Rufous oculocutaneous albinism in southern African Blacks is caused by mutations in the TYRP1 gene. Am J Hum Genet 1997, 61:1095-1101
35. O'Brien PJ: Molecular mechanisms of quinone cytotoxicity. Chem Biol Interact 1991, 80:1-41
36. Schallreuter KU, Moore J, Wood JM, Beazley WD, Gaze DC, Tobin DJ, Marshall HS, Panske A, Panzig E, Hibberts NA: In vivo and in vitro evidence for hydrogen peroxide (H2O2) accumulation in the epidermis of patients with vitiligo and its successful removal by a UVB-activated pseudocatalase. J Investig Dermatol Symp Proc 1999, 4:91-96
37. Beazley WD, Gaze D, Panske A, Panzig E, Schallreuter KU: Serum selenium levels and blood glutathione peroxidase activities in vitiligo. Br J Dermatol 1999, 141:301-303
38. Passi S, Grandinetti M, Maggio F, Stancato A, De Luca C: Epidermal oxidative stress in vitiligo. Pigment Cell Res 1998, 11:81-85
39. Koca R, Armutcu F, Altinyazar HC, Gurel A: Oxidant-antioxidant enzymes and lipid peroxidation in generalized vitiligo. Clin Exp Dermatol 2004, 29:406-409
40. Agrawal D, Shajil EM, Marfatia YS, Begum R: Study on the antioxidant status of vitiligo patients of different age groups in Baroda. Pigment Cell Res 2004, 17:289-294
41. Lamoreux ML, Boissy RE, Womack JE, Nordlund JJ: The vit gene maps to the mi (microphthalmia) locus of the laboratory mouse. J Hered 1992, 83:435-439
42. Tripathi RK, Flanders DJ, Young TL, Oetting WS, Ramaiah A, King RA, Boissy RE, Nordlund JJ: Microphthalmia-associated transcription factor (MITF) locus lacks linkage to human vitiligo or osteopetrosis: an evaluation. Pigment Cell Res 1999, 12:187-192
43. Kitamura R, Tsukamoto K, Harada K, Shimizu A, Shimada S, Kobayashi T, Imokawa G: Mechanisms underlying the dysfunction of melanocytes in vitiligo epidermis: role of SCF/KIT protein interactions and the downstream effector, MITF-M. J Pathol 2004, 202:463-475
44. Jimenez-Cervantes C, Garcia-Borron JC, Valverde P, Solano F, Lozano JA: Tyrosinase isoenzymes in mammalian melanocytes. 1. Biochemical characterization of two melanosomal tyrosinases from B16 mouse melanoma. Eur J Biochem 1993, 217:549-556
45. Zhao H, Zhao Y, Nordlund JJ, Boissy RE: Human TRP-1 has tyrosine hydroxylase but no dopa oxidase activity. Pigment Cell Res 1994, 7:131-140
46. Ancans J, Flanagan N, Hoogduijn MJ, Thody AJ: P-locus is a target for the melanogenic effects of MC-1R signaling: a possible control point for facultative pigmentation. Ann NY Acad Sci 2003, 994:373-377
47. Staleva L, Manga P, Orlow SJ: The pink-eyed dilution protein modulates arsenic sensitivity and intracellular glutathione metabolism. Mol Cell 2002, 13:1406-1420
48. McGill GG, Horstmann M, Widlund HR, Du J, Motyckova G, Nishimura EK, Lin YL, Ramaswamy S, Avery W, Ding HF, Jordan SA, Jackson IJ, Korsmeyer SJ, Golub TR, Fisher DE: Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 2002, 109:707-718
49. Cenas N, Nivinskas H, Anusevicius Z, Sarlauskas J, Lederer F, Arner ES: Interactions of quinones with thioredoxin reductase: a challenge to the antioxidant role of the mammalian selenoprotein. J Biol Chem 2004, 279:2583-2592
50. Lame MW, Jones AD, Wilson DW, Segall HJ: Protein targets of 1,4-benzoquinone and 1,4-naphthoquinone in human bronchial epithelial cells. Proteomics 2003, 3:479-495
51. Wadhwa R, Yaguchi T, Hasan MK, Mitsui Y, Reddel RR, Kaul SC: Hsp70 family member, mot-2/mthsp70/GRP75, binds to the cytoplasmic sequestration domain of the p53 protein. Exp Cell Res 2002, 274:246-253